@FiercePharma: Report: Sanofi approaches Genzyme with buyout deal. Article | Follow @FiercePharma
> The U.S. Senate dropped a House provision that would have restricted brand-name drug companies from paying generic-drug makers to delay putting lower-priced pharmaceuticals on the market. Report
> New documents show submarine maker Electric Boat is buying Pfizer's former global research and development complex in Connecticut for $55 million. News
> More than 600 workers at AstraZeneca's Macclesfield, England, drug factory are holding a strike ballot over changes to their pension scheme. Article
> Spanish pharmaceutical company Almirall reached an agreement with Pfizer to distribute the U.S. company's new osteoporosis drug, Conbriza, in Spain. Story
> The FDA has asked Ampac Fine Chemicals for a more detailed plan to fix manufacturing deviations at its API plant in Rancho Cordova, California. Report
> Israel's Comptroller has launched an investigation into the financial ties between drugmakers and various health-care organizations. Item
> Daiichi Sankyo will form a joint venture with Kitasato Institute Research Center for Biologicals to make vaccines as early as next spring, Nikkei English News said. Report
> GlaxoSmithKline is set to receive a green light to use its anti-clotting drug Arixtra to prevent spontaneous superficial-vein thrombosis. Story
> Glenmark Pharmaceuticals said a unit has received tentative FDA approval to sell a generic version of Medicis Pharmaceutical's Vanos cream for treating skin problems. News
Biotech News
@FierceBiotech: GlobeImmune cuts 25 percent of staff. Article | Follow @FierceBiotech
> Is a bidding war for Genzyme looming? Article
> Cerenis lands $65M for mid-stage cholesterol drug program. Item
> Sandoz chief predicts big wave of biosimilars. Report
> Immune Design nabs $32M for vaccine development. Article
> Onyx will seek early approval on blockbuster cancer candidate. Story
Biotech IT News
> E-clinical solution adds mobility, language support. Article
> Cancer trials halted amid investigations. News
> Halt to Pfizer, GSK trials tests e-clinical data savvy. Report
> Service locates lost trial subjects, data. Story
And Finally... Pfizer has put two widely used mental health assessment tools online for the public to use. Report